Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE1503.10110.6 (+7.94 %)

PREV CLOSE ( ) 1392.50

OPEN PRICE ( ) 1432.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 25023

TODAY'S LOW / HIGH ( )1391.30 1528.35

52 WK LOW / HIGH ( )482.5 1675.25

NSE1503.65111.45 (+8.01 %)

PREV CLOSE( ) 1392.20

OPEN PRICE ( ) 1408.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1503.65 (713)

VOLUME 618632

TODAY'S LOW / HIGH( ) 1392.30 1529.00

52 WK LOW / HIGH ( )482 1675

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

-627.24

-2676.31

-6525.13

2893.80

485.08

Adjustment

8182.74

6821.92

5822.74

3633.15

5274.87

Changes In working Capital

-787.32

-4577.95

-1899.04

-3280.54

-3262.30

Cash Flow after changes in Working Capital

6768.18

-432.34

-2601.43

3246.41

2497.65

Cash Flow from Operating Activities

7010.65

444.11

-2578.15

4814.37

2047.87

Cash Flow from Investing Activities

-1502.50

3024.74

-1187.33

-5208.21

13061.59

Cash Flow from Financing Activities

-6933.23

-2139.21

4213.16

-157.96

-17094.49

Net Cash Inflow / Outflow

-1425.08

1329.64

447.68

-551.80

-1985.03

Opening Cash & Cash Equivalents

3035.01

1707.30

1258.34

1822.34

3658.89

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

-1.35

-3.39

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

1.62

1.46

1.28

-12.20

148.48

Closing Cash & Cash Equivalent

1610.20

3035.01

1707.30

1258.34

1822.34